uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Progressive Multifocal Leukoencephalopathy and Systemic Lupus Erythematosus: Focus on Etiology
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Neurology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Neurology.
Ctr Hosp Lisboa Cent, Hosp Curry Cabral, Serv Med 7 2, Unidade Doencas Autoimunes, Lisbon, Portugal..
Ctr Hosp Lisboa Cent, Hosp Curry Cabral, Serv Med 7 2, Unidade Doencas Autoimunes, Lisbon, Portugal..
2016 (English)In: Case Reports in Neurology, ISSN 1662-680X, E-ISSN 1662-680X, Vol. 8, no 1, 59-65 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Progressive multifocal leukoencephalopathy (PML) caused by reactivation of the JC virus (JCV), a human polyomavirus, occurs in autoimmune disorders, most frequently in systemic lupus erythematosus (SLE). We describe a HIV-negative 34-year-old female with SLE who had been treated with immunosuppressant therapy (IST; steroids and azathioprine) since 2004. In 2011, she developed decreased sensation and weakness of the right hand, followed by vertigo and gait instability. The diagnosis of PML was made on the basis of brain MRI findings (posterior fossa lesions) and JCV isolation from the cerebrospinal fluid (700 copies/ml). IST was immediately discontinued. Cidofovir, mirtazapine, mefloquine and cycles of cytarabine were sequentially added, but there was progressive deterioration with a fatal outcome 1 year after disease onset. This report discusses current therapeutic choices for PML and the importance of early infection screening when SLE patients present with neurological symptoms. In the light of recent reports of PML in SLE patients treated with rituximab or belimumab, we highlight that other IST may just as well be implicated. We conclude that severe lymphopenia was most likely responsible for JCV reactivation in this patient and discuss how effective management of lymphopenia in SLE and PML therapy remains an unmet need.

Place, publisher, year, edition, pages
2016. Vol. 8, no 1, 59-65 p.
Keyword [en]
Progressive multifocal leukoencephalopathy, Systemic lupus erythematosus, Lymphopenia
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-299804DOI: 10.1159/000444874ISI: 000378535900010PubMedID: 27065427OAI: oai:DiVA.org:uu-299804DiVA: diva2:950140
Available from: 2016-07-27 Created: 2016-07-27 Last updated: 2017-11-28Bibliographically approved

Open Access in DiVA

fulltext(733 kB)76 downloads
File information
File name FULLTEXT01.pdfFile size 733 kBChecksum SHA-512
89e885b57c7fdff4b4f7401b1a36eb2d451e1db75c11aed41a9f17a85f189760bdebb09d2bcf2cddc8f1227ed253a77aa60313a6a10aed2ed909b0d99bdb5930
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Berntsson, Shala GhaderiKatsarogiannis, Evangelos

Search in DiVA

By author/editor
Berntsson, Shala GhaderiKatsarogiannis, Evangelos
By organisation
Neurology
In the same journal
Case Reports in Neurology
Neurology

Search outside of DiVA

GoogleGoogle Scholar
Total: 76 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 324 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf